LabCompass

Publications

78

Citations

8,587

Est. group size

Recurring co-author estimate

Active years

29

Publishing since 1998

Research summary
AI-generated

Elizabeth S. Yeh studies the molecular biology of breast cancer, with a focus on the signaling enzyme HUNK (a kinase) and how it drives tumor growth, spread (metastasis), and resistance to therapy, particularly in HER2-positive and triple-negative breast cancers. Her work includes developing drug-like inhibitors targeting these pathways and examining processes such as autophagy (cellular self-recycling) and immune cells within tumors. She also publishes on pharmacology education and inclusive teaching practices.

Breast cancer molecular biologyHUNK kinase signalingCancer therapeutic resistance and drug developmentTumor immunology and metastasisPharmacology education

Publication activity has been relatively steady over the past five years, averaging about five papers per year, following a peak in 2019.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 5.0/year recently
2017: 5 publications172018: 3 publications182019: 12 publications12192020: 4 publications202021: 6 publications212022: 8 publications222023: 5 publications232024: 6 publications242025: 5 publications252026: 1 publication26
Recent publications
Publishes in
  • Journal of Pharmacology and Experimental Therapeutics×5
  • Oncogene×4
  • Biomedicines×4
  • International Journal of Molecular Sciences×3
  • Elsevier eBooks×3

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile